BiomX (NYSEAMERICAN:PHGE – Get Free Report) will likely be posting its quarterly earnings results before the market opens on Wednesday, April 2nd. Analysts expect the company to announce earnings of ($1.65) per share for the quarter.
BiomX Price Performance
PHGE opened at $0.56 on Tuesday. The company has a market capitalization of $10.10 million, a P/E ratio of -0.17 and a beta of 1.27. BiomX has a twelve month low of $0.48 and a twelve month high of $4.99.
Analysts Set New Price Targets
Separately, HC Wainwright restated a “buy” rating and set a $2.00 price target on shares of BiomX in a report on Wednesday, January 8th.
BiomX Company Profile
BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).
Featured Articles
- Five stocks we like better than BiomX
- How to Find Undervalued Stocks
- 3 Buyable Stocks With Solid Bottoms Ready to Rebound
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Advantage+ Shopping: Meta’s Fast Growing $20 Billion AI-Ads Star
- How to Read Stock Charts for Beginners
- Robotaxi News: What Tesla and Lyft Headlines Mean for Shares
Receive News & Ratings for BiomX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BiomX and related companies with MarketBeat.com's FREE daily email newsletter.
